Novo Nordisk A/S (NONOF)

AI Score

Unlock

57.20

-0.58 (-1.00%)

At close: Apr 21, 2025, 3:55 PM

Novo Nordisk A/S Balance Sheet Statement

Financials in DKK. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	15.65B	14.39B	12.65B	10.72B	12.76B	15.47B	15.64B	18.85B	18.69B
Short-Term Investments	10.65B	15.84B	10.92B	6.76B	n/a	n/a	n/a	2.3B	2.01B
Long-Term Investments	2.68B	1.66B	1.34B	1.44B	1.65B	1.81B	1.77B	1.76B	2.2B
Other Long-Term Assets	4.02B	1.43B	206M	267M	674M	841M	n/a	n/a	n/a
Receivables	87.41B	75.26B	57.51B	46.8B	32.18B	29.15B	26.89B	23.55B	24.2B
Inventory	40.85B	31.81B	24.39B	19.62B	18.54B	17.64B	16.34B	15.37B	14.34B
Other Current Assets	6.33B	2.34B	9.67B	7.85B	6.78B	4.43B	4.31B	5.69B	529M
Total Current Assets	160.9B	139.65B	108.19B	85.59B	65.81B	62.46B	59.07B	60.08B	59.77B
Property-Plant & Equipment	162.49B	90.96B	66.67B	55.36B	50.27B	50.55B	41.89B	35.25B	30.18B
Goodwill & Intangibles	111.09B	60.41B	51.42B	43.17B	20.66B	5.83B	5.14B	3.33B	2.71B
Total Long-Term Assets	304.9B	174.84B	133.06B	108.91B	79.11B	63.16B	51.7B	42.27B	37.77B
Total Assets	465.8B	314.49B	241.26B	194.51B	144.92B	125.61B	110.77B	102.36B	97.54B
Account Payables	28.85B	25.61B	15.59B	8.87B	5.72B	6.36B	6.76B	5.61B	6.01B
Deferred Revenue	n/a	n/a	n/a	55.18B	38.73B	35.33B	44.87B	39.44B	38.62B
Short-Term Debt	11.78B	5.3B	480M	12.86B	6.68B	659M	515M	1.69B	229M
Other Current Liabilities	165.85B	38.14B	103.89B	21.78B	18.37B	15.82B	40.31B	29.89B	32.15B
Total Current Liabilities	217.53B	169.66B	120.94B	99.52B	70.27B	58.98B	54.16B	47.06B	47.44B
Long-Term Debt	84.25B	15.98B	20.77B	9.65B	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	9.68B	7.58B	5.45B	360M	5.92B	5.95B	4.65B	4.64B	4.82B
Total Long-Term Liabilities	104.78B	38.27B	36.83B	24.25B	11.32B	9.04B	4.77B	5.48B	4.83B
Total Liabilities	322.31B	207.93B	157.77B	123.76B	81.6B	68.02B	58.93B	52.54B	52.27B
Total Debt	102.79B	27.01B	25.78B	26.64B	10.36B	4.48B	515M	1.69B	229M
Common Stock	446M	451M	456M	462M	470M	480M	490M	500M	510M
Retained Earnings	144.45B	104.84B	80.59B	72B	63.77B	57.82B	53.41B	48.98B	46.11B
Comprehensive Income	-1.41B	1.28B	2.45B	-1.71B	-911M	-694M	-2.05B	349M	-1.34B
Shareholders Equity	143.49B	106.56B	83.49B	70.75B	63.33B	57.59B	51.84B	49.81B	45.27B
Total Investments	13.33B	17.5B	12.26B	8.21B	1.65B	1.81B	1.77B	1.76B	4.21B